Natural history of opportunistic disease in an HIV-infected urban clinical cohort

Annals of Internal Medicine

Volumn 124, Issue 7, 1996, Pages 633-642

  Moore, Richard D ^a   Chaisson, Richard E ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; COTRIMOXAZOLE; FLUCONAZOLE; RIFABUTIN;

ADULT; ARTICLE; BACTEREMIA; CANDIDIASIS; COHORT ANALYSIS; ESOPHAGITIS; FEMALE; FUNGAL MENINGITIS; HERPES ZOSTER; HISTORY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM TUBERCULOSIS; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROBABILITY; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SURVIVAL; TOXOPLASMOSIS; URBAN POPULATION;

EID: 0030002879     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-7-199604010-00003     Document Type: Article

References (52)

1. Update on acquired immune deficiency syndrome (AIDS) - United States. MMWR Morb Mortal Wkly Rep. 1982,31 507-14
2. Jaffe HW, Bregman DJ, Selik RM. Acquired immune deficiency syndrome in the United States first 1,000 cases J Infect Dis 1983,148.339-45.
3. Selik RM, Haverkis HW, Curren JW. Acquired immune deficiency syndrome (AIDS) trends in the United States, 1978-1982 Am J Med 1984,76: 493-500
4. Moore RD, Keruly J, Richman DD, Creagh-Kirk T, Chaisson RE. Natural history of advanced HIV disease in patients treated with zidovudine The Zidovudine Epidemiology Study Group. AIDS. 1992,6 671-7.
5. Gallant JE, Moore RD, Chaisson RE. Prophylaxis for opportunistic infections in patients with HIV infection Ann Intern Med 1994,120 932-44.
6. Crowe SM, Carlin JB, Stewart KI, Lucas CR, Hoy JF. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immun Defic Syndr. 1991, 4:770-6
7. Holmberg SD, Buchbinder SP, Conley U, Wong LC, Katz MH, Penley KA, et al. The spectrum of medical conditions and symptoms before acquired immunodeficiency syndrome in homosexual and bisexual men infected with the human immunodeficiency virus Am J Epidemiol. 1996,141 395-403.
8. Masur H, Ognibene FP, Yarchoan R, Shelhamer JH, Travis W, Suffredini AF, et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med. 1989,111. 223-31
9. Phair J, Munoz A, Detels R, Kaslow R, Rinaldo C, Saah A. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1 Multicenter AIDS Cohort Study Group. N Engl J Med. 1990,322:161-5
10. Chaisson RE, Moore RD, Richman DD, Keruly J, Creagh T. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudie. The Zidovudine Epidemiology Study Group. Am Rev Respir Dis 1992,146. 285-9.
11. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with Zidovudine The Zidovudine Epidemiology Study Group. J Infect Dis 1992,166 1223-7
12. Moore RD, Kessler H, Richman RD, Flexner C, Chaisson RE. Non-Hodgkin's lymphoma in patients with advanced HIV infection treated with zidovudine. JAMA. 1991,265:2208-11.
13. Fischl MA, Dickinson GM, La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS JAMA. 1988,259 1185-9
14. Schneider MM, Hoepelman AI, Eeftinck Schattenkerk JK, Nielsen TL, van der Graaf Y, Frissen JP, et al. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. N Engl J Med 1992,327: 1836-41
15. Leoung GS, Feigal DW Jr, Montgomery AB, Corkery K, Wardlaw L, Adams M, et al. Aerosolized pentamidine for prophylaxis against Pneumocyste carinii pneumonia The San Francisco community prophylaxis trial N Engl J Med 1990;323 769-75
16. Bozette SA, Finkelstein DM, Spector SA, Frame P. Powderly WG, He W, et al. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection NIAID Aids Clinical Trials Group. N Engl J Med. 1995,332.693-9
17. Nightingale SD, Cameron DW, Gordln FM, Sullam PM, Cohn DL, Chaisson RE, et al. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS N Engl J Med 1993,329 828-33
18. Powderly WG, Finkelstein D, Feinberg J, Frame P, He W, van der Horst C, et al. A randomized trial comparing fluconazole with dotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N Engl J Med. 1995;332 700-5.
19. Carr A, Tindall B, Brew BJ, Marriott DJ, Harkness JL, Penny R. Low-dose trimethoprirn-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 1992;117:106-11.
20. Pape JW, Jean SS, Ho JL, Hafner A, Johnson WD Jr. Effect of isoniazid on incidence of active tuberculosis and progression of HIV infection Lancet. 1993,342 268-72
21. Bartlett JG. Medical Management of HIV Infection Glenview, IL Physicians & Scientists: 1994.
22. AIDS among racial/ethnic minorities-United States, 1993 MMWR Morb Mortal Wkly Rep 1994;43:644-55.
23. Update: AIDS among women-United States, 1994 MMWR Morb Mortal Wkly Rep 1995,44 81-4.
24. Moore RD, Stanton D, Gopalan R, Chaisson RE. Racial differences in the use of drug therapy for HIV disease in an urban community N Engl J Med 1994,330 763-8.
25. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults MMWR Morb Mortal Wkly Rep. 1992,41(RR-17) 1-19
26. Lilienfeld MM, Lilienfeld DE. Foundations of Epidemiology New York: Oxford Univ Pr; 1980 336-8.
27. Cox DR. Regression models and life-tables Journal of the Royal Statistical Society 1972,34:187-220
28. Kaplan EI, Meier P. Nonparametric estimation from incomplete observations Journal of the American Statistics Association. 1958,53:457-81.
29. Chaisson RE, Keruly J, Richman DD, Moore RD. Pneumocytis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine The Zidovudine Epidemiology Study Group Arch Intern Med. 1992,152:2009-13
30. Hardy WD, Feinberg J, Finkelstein DM, Power ME, He W, Kaczka C, et al. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. N Engl J Med 1992,327.1842-8.
31. Bozzette SA, Finkelstein DM, Spector SA, Frame P, Powderly WG, He W, et al. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection NIAID AIDS Clinical Trials Group. N Engl J Med 1995;332 693-9
32. Powderly WG, Finkelstein DM, Feinberg J, Frame P, He W, van der Horst C, et al. A randomized trial comparing fluconazole with dotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection NIAID AIDS Clinical Trials Group N Engl J Med. 1995,332:700-5.
33. Glesby M, Moore RD, Chaisson RE. Clinical spectrum of herpes zoster in adults with HIV. Clin Infect Dis 1995;21 370-5
34. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med. 1995, 332 1181-5
35. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995,332.1186-91.
36. Hamilton-Dutolt SJ, Pallesen G, Franzman MB, Karkov J, Black F, Skinhoj P, et al. AIDS-related lymphoma. Histopathology, immunophenotype. and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. Am J Pathol 1991;138:149-63.
37. Pluda JM, Yarchoan R, Jaffe ES, Feuerstein IM, Solomon D, Steinberg SM, et al. Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy. Ann Intern Med. 1990,113:276-82.
38. Rutherford GW, Schwarcz SK, Lemp GF, Barnhart JL, Rauch KJ, Warner WL, et al. The epidemiology of AIDS-related Kaposi's's sarcoma in San Francisco J Infect Dis. 1989;159:569-72.
39. Bacchetti P, Osmond D, Chaisson RE, Dritz S, Rutherford GW, Swig L, et al. Survival patterns of the first 500 patients with AIDS in San Francisco J Infect Dis 1988; 157:1044-7.
40. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine Zidovudine Epidemiology Study Group. Arch Intern Med. 1994;154 566-72.
41. Spector SA, McKinley G, Drew WL, Stempier MJ. A randomized, double-blind study of the efficacy and safety of oral ganciclovir for the prevention of cytomegalovirus disease in HIV-infected patients [Abstract] Second National Conference on Human Retroviruses Washington, DC, February 1995.
42. Zangerle R, Allerberger F. Effect of prophylaxis against Pneumocystis carinii on toxoplasma encephalitis [Letter] Lancet. 1991;337.1232
43. Porter SB, Sande MA. Toxoplasmosis of the central nervous system in acquired immunodeficiency syndrome. N Engl J Med. 1992,327 1643-8
44. Bacellar H, Munoz A, Miller EN, Cohen BA, Besley D, Selnes OA, et al. Temporal trends in the incidence of HIV-1-related neurologic disease: Multicenter AIDS Cohort Study, 1985-1992 Neurology 1994,44 1892-900
45. McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, et al. Dementia in AIDS patients incidence and risk factors. Neurology 1993, 43:2245-53
46. Sidtis JJ, Gatsonis C, Price RW, Singer EJ, Collier AC, Richman DD, et al. Zidovudine treatment of the AIDS dementia complex: results of a placebocontrolled trial AIDS Clinical Trial Group Ann Neurol 1993,33 343-9
47. Alwood K, Keruly J, Moore-Rice K, Stanton DL, Chaulk CP, Chaisson RE. Effectiveness of supervised, intermittent therapy for tuberculosis in HIV-infected patients AIDS 1994;8:1103-8
48. Chaulk CP, Moore-Rice K, Rizzo R, Chaisson RE. Eleven years of community-based directly observed therapy for tuberculosis JAMA 1995;274:945-51.
49. Gillespie SM, Chang Y, Lemp G, Arthur R, Buchbinder S, Steimle A, et al. Progressive multifocal leukoencephalopathy in persons infected with human immunodeficiency virus, San Francisco, 1981-1989. Ann Neurol 1991, 30:597-604.
50. + T lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses The Adult and Adolescent Spectrum of HIV Disease Project Group Arch Intern Med 1995,155 1537-42
51. Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of HIV disease N Engl J Med 1995,333:751-6.
52. USPHS/ISDA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus a summary. MMWR Morb Mortal Wkly Rep 1995,44(RR-8) 1-34.